Join Us Monday, March 4, 2019 from 4-5 pm at the PMSI Admin Building at 1601 Medical Drive, Pottstown PA  19464.  Get Healthy, Stay Healthy, and Avoid Diabetes!  Call or email Debbie Zlomek at 484-318-0566, or Amanda Kulp at 484-318-6562,

3rd Annual Diabetes Health Fair

We would like to thank our patients and sponsors that attended the 3rd Annual Diabetes Health Fair held this past Saturday, November 10, 2018.  Thanks to all of the vendors who helped sponsor the event.  It was a huge success!

Patient Educator Deb Zlomek, RN, CDE featured on the Healthy Interactions Blog

Our Patient Educator Deb Zlomek, RN, CDE Deb Zlomek recently sat down with Nick Armes, a Business Analyst at Healthy Interactions. She spoke about utilizing tools to assist our patients learn ways to deal with their chronic conditions.

To read the featured article, please click on the link below:

The COPD and CHF Map Program Interview with Deb Zlomek

New Therapy to Prevent Stroke

Phoenixville Hospital is among the first selected hospitals in the nation to offer a complete new therapy for stroke prevention for patients with non-valvular atrial fibrillation (AF). WATCHMAN, Left Atrial Appendage Closure (LAAC) Implant is an alternative to long-term warfarin medication (blood thinner).
People with atrial fibrillation have a five times greater risk of stroke.  Atrial fibrillation can cause blood to pool and form clots in the Left Atrial Appendage (LAA), blind pouch in the top left chamber of the heart.  For patients with non-valvular AF, the LAA is the source of the majority of stroke-causing blood clots coming from the heart (about 90% of the time). If a clot forms in the LAA, it can increase one’s risk of having a stroke. Blood clots can break loose and travel in the blood stream to the brain, lungs, and other parts of the body.

Many patients with AF are at considerable risk of stroke and have to be on blood thinner medication. It is deemed not to be suitable to take Warfarin long term, and now they have an alternative option. WATCHMAN LAAC Implant is an alternative therapy to reduce their risk of AF-related stroke. The WATCHMAN Implant closes off LAA and prevent clot formation inside LAA. By closing off the LAA, the risk of stroke is reduced and, over brief period of time, most of the patients  can stop taking warfarin. 
“The new WATCHMAN LAAC Implant provides physicians with a breakthrough therapy for stroke prevention  for patients with non-valvular AF,” said Cardiologist/Electrophysiologist Vadim Levin, MD, who performs WATCHMAN procedures only at Phoenixville Hospital.  “For patients with non-valvular atrial fibrillation who are seeking an alternative to warfarin, the WATCHMAN Implant offers a potentially life-changing option. Watchman device prevent clot related stroke in patients with AF almost as good as warfarin therapy but without long term risk of bleeding unavoidable with warfarin drug".
Phoenixville hospital was one the first hospitals in Pennsylvania starting performing this procedure with the first Watchman device implanted in August 2015. Since that time Dr. Levin , PMSI Cardiology at Phoenixville Hospital is one of most the experienced physicians not only in our area but in state of Pennsylvania.

Implanting the WATCHMAN Device is a one-time procedure that usually lasts about an hour. Following the procedure, patients typically need to stay in the hospital for 24 hours.

About Atrial Fibrillation
Atrial fibrillation (AF) is a heart condition where the upper chambers of the heart (atrium) beat too fast and with irregular rhythm (fibrillation). AF is the most common cardiac arrhythmia, currently affecting more than five million Americans.  Twenty percent of all strokes occur in patients with AF, and AF-related strokes are more frequently fatal and disabling. The most common treatment to reduce stroke risk in patients with AF is blood-thinning warfarin medication.  Despite its proven efficacy, long-term warfarin medication is not well-tolerated by many patients and carries a significant risk for bleeding complications.  Nearly half of AF patients eligible for warfarin are currently untreated due to tolerance and adherence issues.

The WATCHMAN Implant is designed to close the LAA in order to prevent blood clots forming in  the LAA and  entering the blood stream and potentially causing a stroke for patients with non-valvular AF.  The WATCHMAN Implant has been approved in Europe since 2009 and is FDA-approved in the United States since March 2015. It has been implanted in more than 10,000 patients and is approved in more than 70 countries around the world.For more information on the WATCHMAN Implant, please visit:

Dr. Vadim Levin is anelectrophysiologist with PMSI Cardiology. To schedule an appointment with Dr. Levin to learn more about the WATCHMAN implant, call 610 326-8005, extension 184.

Electrophysiologist Vadim Levin, MD, is one of the region’s most experienced physicians in treating patients with atrial fibrillation.  Dr. Levin is proud to be among the first few physicians in the state of Pennsylvania to offer perform the WATCHMAN implant procedure at Phoenixville Hospital. Widely-published in medical journals and a participant in several clinical trials, Dr. Levin is passionate about offering personalized, state-of-the-art care to his patients.

PMSI's Diabetic Education Program Reaccreditation Approved!

PMSI's Diabetic Education Program continues to keep accreditation with the AADE DSME/T Program.

Congratulations to PMSI's Diabetic Educator, Debbie Zlomek, RN, MSN, CDE, BC-ADM, for completing the renewal process for PMSI! PMSI's diabetic program will continue to be included as one of the many diabetes education programs that have achieved accrediation and is in compliance with the National Standards! Our program will be listed on the AADE's (American Association of Diabetes Educators) on-line list of accredited programs on their website.

ABI Testing

Untitled(3)20180523 29149 hil9jl

Vascular Lab at PMSI

Untitled(2)20180523 11016 vl7all